Navigation Links
A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits
Date:7/14/2009

n problem is memory. However, not everyone diagnosed with MCI goes on to develop Alzheimer's. There is currently no treatment for MCI approved by the FDA. Numerous clinical trials are investigating treatments to delay or prevent Alzheimer's in MCI populations.

Scott Roberts, PhD, Assistant Professor of Health Behavior & Health Education at the University of Michigan's School of Public Health; Jason Karlawish, MD, Associate Professor of Medicine and Medical Ethics with tenure, Senior Fellow of the Center for Bioethics and the Leonard Davis Institute of Health Economics, and Associate Scholar at the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania; and colleagues sought to assess how neurologists are diagnosing and treating patients with mild cognitive symptoms and how they view MCI as a clinical diagnosis. They surveyed members of the AmericanAcademy of Neurology (AAN) who had indicated a clinical practice focus on aging/dementia or behavioral neurology in a recent AAN Member Census using mail, fax and the Internet.

420 clinicians (response rate=48%) completed the survey. 88% reported at least monthly encounters with patients experiencing mild cognitive symptoms. Most respondents recognize MCI as a clinical diagnosis (90%) and use its diagnostic code for billing purposes (70%). When seeing this population, most respondents report routinely making recommendations for monitoring and follow-up (88%), counseling patients on physical (78%) and mental exercise (75%), and communicating about risk of dementia (63%).

Most respondents (70%) prescribe cholinesterase inhibitors at least sometimes for this population, with memantine (39%) and "other" agents (e.g., vitamin E, gingko) prescribed less frequently. Cholinesterase inhibitors and memantine are FDA-approved drugs for Alzheimer's. Relatively few respondents routinely provide information on support services (27%) or a wr
'/>"/>

SOURCE Alzheimer's Association
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Manic phase of bipolar disorder benefits from breast cancer medication
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... to a gynaecologist or midwife are generally associated ... could offer so much more. Women, doctors and ... opportunities for dialogue about sexual health, reveals a ... of Gothenburg, Sweden. , Many young women see ... 500 women aged 23-29 answered questions about their ...
(Date:12/15/2009)... Scientists seeking to understand how to make an AIDS ... It turns out that the immune system can indeed ... antibodies but at the same time, the immune ... are eliminated before they have a chance to mature. ... antibody against a viral disease is under the control ...
(Date:12/15/2009)... Agency has requested documents from an investigative journalist, even though ... under the Freedom of Information Act. , ... ... bizarre about-face, the secretive Central Intelligence Agency has requested documents ... obtained them from the CIA itself under the Freedom of ...
(Date:12/15/2009)... safer than wood fiber , , TUESDAY, Dec. 15 (HealthDay News) ... in a fall are much lower on playgrounds with granite ... research has found. , Researchers at the Hospital for Sick ... surfaces of either granite sand or engineered wood fiber. Their ... . , The risk of a broken arm resulting from ...
(Date:12/15/2009)... – Seattle, WA) – Delicious Planet, Seattle’s premier organic meal ... the launch of its Delicious Planet Detox Program, Randi Carter, ... ... (December 15, 2009 – Seattle, WA) – ... ) is accepting orders now for the launch of its ...
Breaking Medicine News(10 mins):Health News:More about sex and relationships needed at gynecological visits 2Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4
... brains of people who are victims of tone-deafness do not ... the current issue of Brain, was conducted by a ... Neurological Institute and the Newcastle University Medical School. Tone ... which impedes normal functioning people to learn even fundamental music ...
... 523 children and adolescents in the United States had ... a major national study called SEARCH for Diabetes in ... diabetes among youth under the age of 20 ever ... Ph.D., M.S., associate professor of epidemiology and prevention at ...
... Osteoarthritis, the degenerative inflammatory bone disease, may be a sign ... print in the Annals of the Rheumatic Diseases. ,The ... people, aged between 30 and 79. Most of them were ... of all participants to check for signs of osteoarthritis and ...
... promise as an anti-cancer agent, inhibiting a gene found ... to researchers at the University of Illinois at Chicago ... Oct. 1 issue of Cancer Research. ,"We ... in cancer cells to screen for promising anti-cancer agents," ...
... sonography shows liver and spleen injuries better than ... // at the University of California, Davis School ... ,This study included 22 liver, spleen ... of the 22 injuries while non-contrast-enhanced sonography revealed ...
... rebuild after years of dictatorship and war, Iraqi craniofacial ... in treating many of the most serious injuries caused ... step forward was last year's "Kuwait Plast 2005" meeting, ... American counterparts in a 5-day exchange of surgical knowledge ...
Other Medicine News:Health News:Understanding Reasons for Tone deafness 2Health News:One in 523 Children and Adolescents Have Diabetes 2Health News:One in 523 Children and Adolescents Have Diabetes 3Health News:Osteoarthritis May be Sign of Faster “Biological Ageing 2Health News:Antibiotic Inhibits Cancer Gene Activity 2Health News:Journal of Craniofacial Surgery Publishes Research by Iraqi Surgeons 2
(Date:12/15/2009)... CLEVELAND, Dec. 15 At today,s regular meeting ... (NYSE: LZ ), the board declared a ... March 10, 2010 to holders of record at the ... About The Lubrizol Corporation ,, The Lubrizol Corporation ... chemical company that produces and supplies technologies that improve ...
(Date:12/15/2009)... -- Ghent University Hospital in Belgium, among the ... treatments using arc therapy, has carried out its ... technology from Varian Medical Systems ( VAR). A ... just 75 seconds, over four times faster than ... would have taken more than five minutes using ...
(Date:12/15/2009)... Vivakor, Inc. (OTC Bulletin Board: ... reported strong performance in 2009. Vivakor is ... with divisional spokes developing multiple products and ... strategy is anchored to the concept of ... Vivakor,s R&D efforts target commercialization and product-specific ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 3Vivakor Divisions Continue to Demonstrate Independent Growth 2Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 5289 1Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 5289 2Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones 5287 1Panasonic Offers U are U 28R 29 Fingerprint Sensor From DigitalPersona on Stingray JS 950 Point of Sale Workstations 10286 1Panasonic Offers U are U 28R 29 Fingerprint Sensor From DigitalPersona on Stingray JS 950 Point of Sale Workstations 10286 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The Precedent establishes a new generation of revision hip stems....
Medicine Products: